Cargando…
Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I
Mucopolysaccharidosis type I (MPS I) is a lysosomal disease caused by α-l-iduronidase (IDUA) deficiency and accumulation of glycosaminoglycans (GAG). Lentiviral vector encoding correct IDUA cDNA could be used for treating MPS I. To optimize the lentiviral vector design, 9 constructs were designed by...
Autores principales: | Ou, Li, Przybilla, Michael J., Koniar, Brenda L., Whitley, Chester B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987501/ https://www.ncbi.nlm.nih.gov/pubmed/27556013 http://dx.doi.org/10.1016/j.ymgmr.2015.11.004 |
Ejemplares similares
-
Phenotype prediction for mucopolysaccharidosis type I by in silico analysis
por: Ou, Li, et al.
Publicado: (2017) -
Toward lentiviral vectors for antiangiogenic ocular gene therapy
por: Askou, Anne Louise, et al.
Publicado: (2023) -
Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA
por: Anson, Donald S, et al.
Publicado: (2007) -
Lentiviral vector design using alternative RNA export elements
por: Oh, Taekeun, et al.
Publicado: (2007) -
Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
por: Poletti, Valentina, et al.
Publicado: (2021)